welbournes

  Department of Health and Social Care (DHSC) has issued a medicine supply notification for Flixotide® (fluticasone) 125micrograms/dose and 250micrograms/dose Evohaler® MSN/2024/074 Tier 2 – medium impact Date of issue: 19th June 2024 Flixotide® (fluticasone) 125micrograms/dose and 250micrograms/dose Evohaler® is out of stock from late June until mid-July 2024. Flixotide® (fluticasone) Accuhaler® 100microgram, 250microgram and [...]

The post Medicine Supply Notification: Flixotide® (fluticasone) 125micrograms/dose and 250micrograms/dose Evohaler® appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Triamcinolone acetonide suspension for injection vials (Kenalog® 40mg/1ml and Adcortyl® 50mg/5ml) MSN/2024/073 Tier 2 – medium impact Date of issue: 18th June 2024 Triamcinolone acetonide suspension for injection vials (Kenalog® 40mg/1ml and Adcortyl® 50mg/5ml) are out of stock until w/c 24th [...]

The post Medicine Supply Notification: Triamcinolone acetonide suspension for injection vials (Kenalog® 40mg/1ml and Adcortyl® 50mg/5ml) appeared first on Community Pharmacy England.

TO NOTE: This MSN is the one of two covering supply issues with insulin vials. MSN/2024/057 issued on 20/05/24 covered Humulin® S (insulin soluble human). This MSN (MSN/2024/072) covers Humalog® (insulin lispro). CAUTION: These products have similar sounding names and appropriate risk minimisation strategies should be implemented to ensure actions are carried out for specific [...]

The post Medicine Supply Notification: Humalog® (insulin lispro) 100units/ml solution for injection 10ml vials appeared first on Community Pharmacy England.

Class 4 Medicines Defect Information: Oxcarbazepine Mylan 150 mg, 300mg, 600mg Film-Coated Tablets (Mylan) Drug alert number: EL (24)A/22 Date issued: 17 June 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Oxcarbazepine Mylan 150 mg, 300mg, 600mg Film-Coated Tablets (Mylan) Company name: Viatris UK Healthcare [...]

The post MHRA Class 4 Medicines Defect Information: Oxcarbazepine Mylan 150 mg, 300mg, 600mg Film-Coated Tablets (Mylan) appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Erythromycin 250mg gastro-resistant tablets MSN/2024/071 Tier 2 – medium impact Date of issue: 12th June 2024 Erythromycin 250mg tablets are currently out of stock until w/c 24th of June 2024. Erythromycin 500mg tablets remain available but are unable to support an [...]

The post Medicine Supply Notification: Erythromycin 250mg gastro-resistant tablets appeared first on Community Pharmacy England.